These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 11669218

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
    Jochum C, Beste M, Zellmer E, Graves SS, Storb R.
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?
    Diaconescu R, Little MT, Leisenring W, Yunusov M, Hogan WJ, Sorror ML, Baron F, Storb R.
    Biol Blood Marrow Transplant; 2005 May; 11(5):335-44. PubMed ID: 15846286
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
    Sandmaier BM, Bethge WA, Wilbur DS, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Storb R.
    Blood; 2002 Jul 01; 100(1):318-26. PubMed ID: 12070043
    [Abstract] [Full Text] [Related]

  • 27. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.
    Biol Blood Marrow Transplant; 2007 Jul 01; 13(7):790-805. PubMed ID: 17580257
    [Abstract] [Full Text] [Related]

  • 28. Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.
    Sandmaier BM, Storb R, Santos EB, Krizanac-Bengez L, Lian T, McSweeney PA, Yu C, Schuening FG, Deeg HJ, Graham T.
    Blood; 1996 Apr 15; 87(8):3508-13. PubMed ID: 8605371
    [Abstract] [Full Text] [Related]

  • 29. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
    McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu C, Blume KG, Storb RF.
    Blood; 2001 Jun 01; 97(11):3390-400. PubMed ID: 11369628
    [Abstract] [Full Text] [Related]

  • 30. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A, Nash RA, Zaucha JM, Little MT, Georges GE, Sale GE, Zellmer E, Kuhr CS, Lothrop CD, Storb R.
    Biol Blood Marrow Transplant; 2003 Nov 01; 9(11):674-82. PubMed ID: 14652850
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
    Chen Y, Fukuda T, Thakar MS, Kornblit BT, Storer BE, Santos EB, Storb R, Sandmaier BM.
    Cytotherapy; 2011 Nov 01; 13(10):1269-80. PubMed ID: 21846291
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Everolimus in combination with mycophenolate mofetil as pre- and post-transplantation immunosuppression after nonmyeloablative hematopoietic stem cell transplantation in canine littermates.
    Machka C, Lange S, Werner J, Wacke R, Killian D, Knueppel A, Knuebel G, Vogel H, Lindner I, Roolf C, Murua Escobar H, Junghanss C.
    Biol Blood Marrow Transplant; 2014 Sep 01; 20(9):1301-6. PubMed ID: 24923538
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS, Mathes DW, Georges GE, Kuhr CS, Chang J, Butts TM, Storb R.
    Transplantation; 2012 Sep 27; 94(6):562-8. PubMed ID: 22929594
    [Abstract] [Full Text] [Related]

  • 38. Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.
    Graves SS, Storer BE, Butts TM, Storb R.
    Biol Blood Marrow Transplant; 2013 Nov 27; 19(11):1650-4. PubMed ID: 23994246
    [Abstract] [Full Text] [Related]

  • 39. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS, Warren EH, Thompson JA, Riddell SR, Childs RW, Otterud BE, Leppert MF, Storb R, Sandmaier BM.
    Clin Cancer Res; 2004 Dec 01; 10(23):7799-811. PubMed ID: 15585611
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.